Upstream Bio, Inc.
UPB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002022626
In the last 90 days, Upstream Bio, Inc. insiders filed 0 open-market purchases and 5 sales; 148 institutions reported holding it in 13F filings for Q2 2026, worth $350.1M in total; no superinvestor holds it.
Superinvestors holding UPB, Q2 2026
No superinvestor reported holding UPB in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of UPB each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2025
0 superinvestors holding at quarter end
- Sold out
- Soros Fund Management
Q4 2024
1 superinvestor holding at quarter end